nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—CYP1A1—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0765	0.0765	CbGpPWpGaD
Flutamide—CYP1A1—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0671	0.0671	CbGpPWpGaD
Flutamide—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0488	0.0488	CbGpPWpGaD
Flutamide—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0428	0.0428	CbGpPWpGaD
Flutamide—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0377	0.0377	CbGpPWpGaD
Flutamide—CYP1B1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.035	0.035	CbGpPWpGaD
Flutamide—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.033	0.033	CbGpPWpGaD
Flutamide—CYP1B1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0307	0.0307	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.0285	0.0285	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.0285	0.0285	CbGpPWpGaD
Flutamide—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0228	0.0228	CbGpPWpGaD
Flutamide—CYP1A1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0215	0.0215	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—CNDP2—pharynx cancer	0.0206	0.0206	CbGpPWpGaD
Flutamide—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.02	0.02	CbGpPWpGaD
Flutamide—CYP1A1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0189	0.0189	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.0188	0.0188	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—ADH7—pharynx cancer	0.0186	0.0186	CbGpPWpGaD
Flutamide—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0176	0.0176	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—ADH1B—pharynx cancer	0.0163	0.0163	CbGpPWpGaD
Flutamide—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0155	0.0155	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.014	0.014	CbGpPWpGaD
Flutamide—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.0138	0.0138	CbGpPWpGaD
Flutamide—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0137	0.0137	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—CNDP2—pharynx cancer	0.0134	0.0134	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—CNDP2—pharynx cancer	0.0127	0.0127	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—ADH7—pharynx cancer	0.0121	0.0121	CbGpPWpGaD
Flutamide—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.012	0.012	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—ADH7—pharynx cancer	0.0114	0.0114	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.011	0.011	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—ADH1B—pharynx cancer	0.0106	0.0106	CbGpPWpGaD
Flutamide—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0106	0.0106	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—pharynx cancer	0.0106	0.0106	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—CNDP2—pharynx cancer	0.0104	0.0104	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—ADH1B—pharynx cancer	0.01	0.01	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—CCND1—pharynx cancer	0.0098	0.0098	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—ADH7—pharynx cancer	0.00937	0.00937	CbGpPWpGaD
Flutamide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0093	0.0093	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.00924	0.00924	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—ADH1B—pharynx cancer	0.00821	0.00821	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.00807	0.00807	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00799	0.00799	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00799	0.00799	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—pharynx cancer	0.00789	0.00789	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—TP53—pharynx cancer	0.00735	0.00735	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.0073	0.0073	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—CCND1—pharynx cancer	0.00724	0.00724	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.0064	0.0064	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.00637	0.00637	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.00623	0.00623	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—EGFR—pharynx cancer	0.00568	0.00568	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.00563	0.00563	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.00494	0.00494	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00492	0.00492	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00492	0.00492	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.00475	0.00475	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00393	0.00393	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.00372	0.00372	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CNDP2—pharynx cancer	0.00351	0.00351	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ADH7—pharynx cancer	0.00318	0.00318	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00314	0.00314	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00314	0.00314	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.00313	0.00313	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.00309	0.00309	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ADH1B—pharynx cancer	0.00279	0.00279	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—B4GALT5—pharynx cancer	0.00266	0.00266	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00259	0.00259	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CNDP2—pharynx cancer	0.00229	0.00229	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CNDP2—pharynx cancer	0.00216	0.00216	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ADH7—pharynx cancer	0.00207	0.00207	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ADH7—pharynx cancer	0.00196	0.00196	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ADH1B—pharynx cancer	0.00182	0.00182	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.00177	0.00177	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—B4GALT5—pharynx cancer	0.00174	0.00174	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ADH1B—pharynx cancer	0.00172	0.00172	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—B4GALT5—pharynx cancer	0.00164	0.00164	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ADH7—pharynx cancer	0.0016	0.0016	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.0014	0.0014	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.00138	0.00138	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.00134	0.00134	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ADH7—pharynx cancer	0.00125	0.00125	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.00109	0.00109	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.00107	0.00107	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.00105	0.00105	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000963	0.000963	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000845	0.000845	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000807	0.000807	CbGpPWpGaD
